Atul Kapoor
Atul Kapoor has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Aprajita Kapur
7 shared publicationsGoldaa Mahajan
Department of Radiology Advanced Diagnostics and Institute of Imaging Amritsar Punjab India
7 shared publicationsAprajita Kapoor
Department of Radiology, Advanced Diagnostics and Institute of Imaging, Amritsar, Punjab, India
3 shared publicationsBholla Singh Sidhu
Departments of Surgery, Parwati Hospital, Amritsar, Punjab, India
3 shared publicationsJasdeep Singh
Departments of Surgery, Sukh Sagar Hospital, Amritsar, Punjab, India
3 shared publicationsNavjot Brar
Department of Surgery, Parwati Hospital, Amritsar, Punjab, India
2 shared publications
Latest Publications
- Open Access
- 17 September 2025
- Published by AccScience Publishing in Artificial Intelligence in Health
- p. 025300062
Artificial intelligence versus elastography in characterizing BI-RADS 4 breast nodules: A systematic review and critical appraisal
Breast imaging reporting and data system (BI-RADS) category 4 breast lesions represent a heterogeneous category with moderate suspicion of malignancy, which pose significant diagnostic challenges. Both artificial intelligence (AI) and elastography have demonstrated potential adjunctive roles in improving the evaluation of these lesions. Given the increasingly pervasive use of AI in the medical field, a systematic and critical evaluation of its diagnostic efficacy, clinical utility, and practical applications, compared with elastography techniques, is warranted for the assessment of BI-RADS 4 breast nodules. A systematic literature search was conducted across multiple databases from January 2010 to December 2024, and the studies were critically appraised using standardized quality assessment tools (e.g., quality assessment of diagnostic accuracy studies-2). Due to the significant heterogeneity in study populations and methodologies, a narrative synthesis approach with comprehensive critical appraisal was employed. A total of 23 studies met the inclusion criteria for AI assessment (n = 15,847 lesions) and 31 for elastography (n = 12,456 lesions). Critical appraisal revealed significant methodological limitations—67% of the studies had a high risk of bias in patient selection, 45% in index-test conduct, and 56% in flow and timing. Only 25% of the studies were considered high quality. AI systems demonstrated promising diagnostic performance in individual studies (reported area under the curve range: 0.82–0.94), while elastography showed consistent but more modest performance (reported area under the curve range: 0.72–0.87). However, the quality of the evidence was insufficient for a reliable comparative assessment. While both technologies show promise, the existing evidence is limited by significant methodological constraints, precluding reliable comparative conclusions. These gaps highlight the need for high-quality prospective head-to-head comparison studies with standardized protocols and rigorous methodology.
- 17 September 2025
- Published by AccScience Publishing in Artificial Intelligence in Health
- p. 025300062
Open AccessArtificial intelligence versus elastography in characterizing BI-RADS 4 breast nodules: A systematic review and critical appraisal
Breast imaging reporting and data system (BI-RADS) category 4 breast lesions represent a heterogeneous category with moderate suspicion of malignancy, which pose significant diagnostic challenges. Both artificial intelligence (AI) and elastography have demonstrated potential adjunctive roles in improving the evaluation of these lesions. Given the increasingly pervasive use of AI in the medical field, a systematic and critical evaluation of its diagnostic efficacy, clinical utility, and practical applications, compared with elastography techniques, is warranted for the assessment of BI-RADS 4 breast nodules. A systematic literature search was conducted across multiple databases from January 2010 to December 2024, and the studies were critically appraised using standardized quality assessment tools (e.g., quality assessment of diagnostic accuracy studies-2). Due to the significant heterogeneity in study populations and methodologies, a narrative synthesis approach with comprehensive critical appraisal was employed. A total of 23 studies met the inclusion criteria for AI assessment (n = 15,847 lesions) and 31 for elastography (n = 12,456 lesions). Critical appraisal revealed significant methodological limitations—67% of the studies had a high risk of bias in patient selection, 45% in index-test conduct, and 56% in flow and timing. Only 25% of the studies were considered high quality. AI systems demonstrated promising diagnostic performance in individual studies (reported area under the curve range: 0.82–0.94), while elastography showed consistent but more modest performance (reported area under the curve range: 0.72–0.87). However, the quality of the evidence was insufficient for a reliable comparative assessment. While both technologies show promise, the existing evidence is limited by significant methodological constraints, precluding reliable comparative conclusions. These gaps highlight the need for high-quality prospective head-to-head comparison studies with standardized protocols and rigorous methodology.
- Open Access
- 28 July 2025
- Published by Medip Academy in International Surgery Journal
- Vol. 12 (8) , 1288-1295
Use of next-generation shear wave elastography for blue breast cancer evaluation
Background: Blue breast cancer is a term used to describe breast nodules that appear deceptively soft (blue) on elastography despite their malignant nature-representing a significant diagnostic challenge in breast imaging. Methods: This prospective study evaluates the efficacy of next-generation shear wave elastography (SWE) technology in the characterization of blue breast cancer through a comprehensive analysis of 150 prospective patients with BIRAD 4-5 solid breast nodules on routine sono-mammography on three different standard elastography systems i.e., Canon Aplio i 800, Mindray Resona i 9 and Siemens Sequoia system (next generation elastography). Results: Our analysis reveals that Siemens next gen 2D-SWE algorithm demonstrated a 88.3% overall improvement in blue cancer detection rate (from 10.0% with Aplio to 98.3% with Sequoia, p85 kPa measurement provides the most reliable diagnostic indicator with near-perfect performance (F1=0.992, AUC=0.992). As a complementary tool to B-mode ultrasound, it enhances clinical confidence in breast lesion assessment and may contribute to earlier cancer detection and improved patient outcomes.
- 28 July 2025
- Published by Medip Academy in International Surgery Journal
- Vol. 12 (8) , 1288-1295
Open AccessUse of next-generation shear wave elastography for blue breast cancer evaluation
Background: Blue breast cancer is a term used to describe breast nodules that appear deceptively soft (blue) on elastography despite their malignant nature-representing a significant diagnostic challenge in breast imaging. Methods: This prospective study evaluates the efficacy of next-generation shear wave elastography (SWE) technology in the characterization of blue breast cancer through a comprehensive analysis of 150 prospective patients with BIRAD 4-5 solid breast nodules on routine sono-mammography on three different standard elastography systems i.e., Canon Aplio i 800, Mindray Resona i 9 and Siemens Sequoia system (next generation elastography). Results: Our analysis reveals that Siemens next gen 2D-SWE algorithm demonstrated a 88.3% overall improvement in blue cancer detection rate (from 10.0% with Aplio to 98.3% with Sequoia, p85 kPa measurement provides the most reliable diagnostic indicator with near-perfect performance (F1=0.992, AUC=0.992). As a complementary tool to B-mode ultrasound, it enhances clinical confidence in breast lesion assessment and may contribute to earlier cancer detection and improved patient outcomes.
- Open Access
- 23 July 2025
- Published by Science Publishing Group in International Journal of Gastroenterology
- Vol. 9 (2) , 152-164
Viscosity Imaging for Detection of Liver Inflammation: A Systematic Review
Background: Chronic liver disease affects millions globally, with inflammation being a critical indicator of disease progression. Current diagnostic methods have limitations in detecting early-stage liver inflammation, delaying intervention and worsening outcomes. Objective: To review evidence on viscosity imaging as a non-invasive technique for detecting liver inflammation, including diagnostic accuracy and comparative effectiveness versus existing methods. Methods: A systematic search of PubMed, Embase, Web of Science, and Cochrane Library was conducted from inception to January 2025. Studies evaluating viscosity imaging for liver inflammation detection were included. Two reviewers screened articles, extracted data, and assessed quality using QUADAS-2. Primary outcomes were diagnostic accuracy and correlation with histological inflammation grades. Results: Of 2,847 records, 45 studies met criteria, comprising 8,234 patients. Viscosity imaging showed sensitivity of 78% (95% CI: 74-82%) and specificity of 76% (95% CI: 72-80%) for moderate-to-severe inflammation. Viscosity parameters correlated with inflammation grades (r=0.48-0.52, p<0.001) independent of fibrosis. In NAFLD/NASH, viscosity imaging achieved higher accuracy (AUROC 0.82) versus elastography (AUROC 0.69, p=0.02). MRE showed superior reproducibility (ICC 0.90-0.96) versus ultrasound methods (ICC 0.82-0.91). Viscosity parameters decreased faster than stiffness after treatment. Conclusion: Viscosity imaging demonstrates moderate-to-good diagnostic accuracy for liver inflammation detection. Combined with elastography, it enables comprehensive liver assessment and supports earlier intervention. Further prospective studies with long-term data are needed to establish clinical utility.
- 23 July 2025
- Published by Science Publishing Group in International Journal of Gastroenterology
- Vol. 9 (2) , 152-164
Open AccessViscosity Imaging for Detection of Liver Inflammation: A Systematic Review
Background: Chronic liver disease affects millions globally, with inflammation being a critical indicator of disease progression. Current diagnostic methods have limitations in detecting early-stage liver inflammation, delaying intervention and worsening outcomes. Objective: To review evidence on viscosity imaging as a non-invasive technique for detecting liver inflammation, including diagnostic accuracy and comparative effectiveness versus existing methods. Methods: A systematic search of PubMed, Embase, Web of Science, and Cochrane Library was conducted from inception to January 2025. Studies evaluating viscosity imaging for liver inflammation detection were included. Two reviewers screened articles, extracted data, and assessed quality using QUADAS-2. Primary outcomes were diagnostic accuracy and correlation with histological inflammation grades. Results: Of 2,847 records, 45 studies met criteria, comprising 8,234 patients. Viscosity imaging showed sensitivity of 78% (95% CI: 74-82%) and specificity of 76% (95% CI: 72-80%) for moderate-to-severe inflammation. Viscosity parameters correlated with inflammation grades (r=0.48-0.52, p<0.001) independent of fibrosis. In NAFLD/NASH, viscosity imaging achieved higher accuracy (AUROC 0.82) versus elastography (AUROC 0.69, p=0.02). MRE showed superior reproducibility (ICC 0.90-0.96) versus ultrasound methods (ICC 0.82-0.91). Viscosity parameters decreased faster than stiffness after treatment. Conclusion: Viscosity imaging demonstrates moderate-to-good diagnostic accuracy for liver inflammation detection. Combined with elastography, it enables comprehensive liver assessment and supports earlier intervention. Further prospective studies with long-term data are needed to establish clinical utility.
- Open Access
- 9 July 2025
- Published by Science Publishing Group in Clinical Medicine Research
- Vol. 14 (4) , 109-114
Reverse Hepatorenal Index: A New Parameter for Detection of Early Chronic Renal Parenchymal Changes
Aim of the Study : Early detection of chronic kidney disease (CKD) remains a clinical challenge. Current diagnostic parameters often identify renal dysfunction only after significant parenchymal damage has occurred. This study introduces the Reverse Hepatorenal Index (RHI), a novel ultrasound-based parameter designed to detect early chronic renal parenchymal changes and evaluates the diagnostic accuracy of the Reverse Hepatorenal Index in detecting early chronic renal parenchymal changes compared to conventional parameters. Material and Methods : A prospective observational study was conducted on 150 participants (75 with early-stage CKD and 75 healthy controls) from January 2025 to May 2025. Ultrasound examinations were performed to measure renal and hepatic echogenicity. The RHI was calculated as the below normal values of the ratio of hepatic cortical echogenicity to renal cortical echogenicity. Serum creatinine, estimated glomerular filtration rate (eGFR), and urinary biomarkers were measured for comparison . Results : The mean RHI was significantly lower in patients with early CKD (0.78 ± 0.12) compared to healthy controls (1.15 ± 0.09) (pConclusion : The Reverse Hepatorenal Index represents a promising non-invasive parameter for early detection of chronic renal parenchymal changes. Its superior performance compared to traditional markers suggests potential clinical utility in CKD screening and monitoring.
- 9 July 2025
- Published by Science Publishing Group in Clinical Medicine Research
- Vol. 14 (4) , 109-114
Open AccessReverse Hepatorenal Index: A New Parameter for Detection of Early Chronic Renal Parenchymal Changes
Aim of the Study : Early detection of chronic kidney disease (CKD) remains a clinical challenge. Current diagnostic parameters often identify renal dysfunction only after significant parenchymal damage has occurred. This study introduces the Reverse Hepatorenal Index (RHI), a novel ultrasound-based parameter designed to detect early chronic renal parenchymal changes and evaluates the diagnostic accuracy of the Reverse Hepatorenal Index in detecting early chronic renal parenchymal changes compared to conventional parameters. Material and Methods : A prospective observational study was conducted on 150 participants (75 with early-stage CKD and 75 healthy controls) from January 2025 to May 2025. Ultrasound examinations were performed to measure renal and hepatic echogenicity. The RHI was calculated as the below normal values of the ratio of hepatic cortical echogenicity to renal cortical echogenicity. Serum creatinine, estimated glomerular filtration rate (eGFR), and urinary biomarkers were measured for comparison . Results : The mean RHI was significantly lower in patients with early CKD (0.78 ± 0.12) compared to healthy controls (1.15 ± 0.09) (pConclusion : The Reverse Hepatorenal Index represents a promising non-invasive parameter for early detection of chronic renal parenchymal changes. Its superior performance compared to traditional markers suggests potential clinical utility in CKD screening and monitoring.
- Open Access
- 26 March 2025
- Published by Science Publishing Group in Cardiology and Cardiovascular Research
- Vol. 9 (2) , 64-68
Concurrent Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: A Rare Phenotypic Overlap
Background: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy (HCM) are distinct inherited cardiac disorders that represent leading causes of sudden cardiac death, particularly in young adults. While both conditions display autosomal dominant inheritance patterns, they typically involve different genetic mutations and pathophysiological mechanisms. Case report: We present a rare case of a 45-year-old male with ventricular tachycardia who demonstrated concurrent phenotypic features of both ARVC and HCM on comprehensive cardiac evaluation. Electrocardiography showed epsilon waves characteristic of ARVC, while cardiac magnetic resonance imaging (CMR) revealed right ventricular dilatation consistent with ARVC alongside mid-ventricular hypertrophic obstructive cardiomyopathy (HOCM). This unusual phenotypic overlap highlights the importance of comprehensive multimodality cardiac imaging and raises intriguing questions about potential genetic and molecular intersections between these cardiomyopathies. Conclusion: This case highlights the importance of comprehensive multimodality cardiac imaging in identifying complex structural abnormalities and raises questions about potential genetic and molecular intersections between ARVC and HCM. Our case also adds to the extremely limited literature documenting the co-occurrence of these conditions and underscores the value of CMR in identifying complex structural cardiac abnormalities. Management of patients with this rare phenotypic overlap presents unique challenges, requiring careful consideration of risk stratification and medical therapy. Further research may provide valuable insights into the pathophysiology and optimal management strategies for patients with overlapping cardiomyopathic phenotypes.
- 26 March 2025
- Published by Science Publishing Group in Cardiology and Cardiovascular Research
- Vol. 9 (2) , 64-68
Open AccessConcurrent Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: A Rare Phenotypic Overlap
Background: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy (HCM) are distinct inherited cardiac disorders that represent leading causes of sudden cardiac death, particularly in young adults. While both conditions display autosomal dominant inheritance patterns, they typically involve different genetic mutations and pathophysiological mechanisms. Case report: We present a rare case of a 45-year-old male with ventricular tachycardia who demonstrated concurrent phenotypic features of both ARVC and HCM on comprehensive cardiac evaluation. Electrocardiography showed epsilon waves characteristic of ARVC, while cardiac magnetic resonance imaging (CMR) revealed right ventricular dilatation consistent with ARVC alongside mid-ventricular hypertrophic obstructive cardiomyopathy (HOCM). This unusual phenotypic overlap highlights the importance of comprehensive multimodality cardiac imaging and raises intriguing questions about potential genetic and molecular intersections between these cardiomyopathies. Conclusion: This case highlights the importance of comprehensive multimodality cardiac imaging in identifying complex structural abnormalities and raises questions about potential genetic and molecular intersections between ARVC and HCM. Our case also adds to the extremely limited literature documenting the co-occurrence of these conditions and underscores the value of CMR in identifying complex structural cardiac abnormalities. Management of patients with this rare phenotypic overlap presents unique challenges, requiring careful consideration of risk stratification and medical therapy. Further research may provide valuable insights into the pathophysiology and optimal management strategies for patients with overlapping cardiomyopathic phenotypes.
- 23 November 2023
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 52 (2) , 163-175
Use of shear wave imaging with intestinal ultrasonography in patients with chronic diarrhea
Objective: A retrospective study was designed to determine the role of shear wave elastography (SWE) and intestinal ultrasonography to differentiate between inflammatory and fibrotic bowel strictures by determining Young's modulus (E) and shear wave dispersion (SWD) and to compare its role with contrast-enhanced computed tomography (CECT) in patients with chronic diarrhea and pain abdomen. Methods: Seventy-six patients who had increased small bowel thickness (SBWT) >3 mm, and large bowel wall thickness (LBWT) >4 mm on intestinal ultrasonography (IUS) were evaluated in a two-step manner. The first step involved classifying patients with increased SBWT >3 mm and LBWT >4 mm by use of SWE and dispersion into three groups that is group I (fibrotic), group II (inflammatory) thickening, and group III (mixed-fibrosis and inflammatory) wall thickening. In the second step, etiological classification was done using six gray scale features of IUS that is length and degree of bowel thickening, presence of bowel stratification, Limberg grade of vascularity, status of mesenteric fat, juxta bowel status-nodes, fluid, and fistula formation to reach to a definitive diagnosis. These findings were compared with findings on CECT. Twenty-three patients had diagnosis confirmed by biopsy while 18 underwent surgery with histologic confirmation of operative findings. The sensitivity, specificity and AUROC for both modalities were compared. Results: Group I that is fibrotic group had 33 patients with fibrotic strictures of which fibrotic Crohn's disease (CD)and tuberculosis of the bowel were the dominant types followed by neoplastic and infective causes. In Group II that is inflammatory there were 32 patients with predominantly infective ileo-colitis, and ulcerative colitis patients while 11 patients were present in group III that is (mixed fibrotic and inflammatory) type of bowel wall thickening and were patients of inflammatory CD, infective ileo-colitis. The presence of length of bowel involvement, Limberg grade, mesenteric fat proliferation, and SBWT>9 mm were the statistically significant parameters on IUS which helped to reach to final diagnosis. The sensitivity and specificity of combined SWE with SWD and IUS were 100% and 99% while that of CECT was 78% and 96% respectively with AUROC of 100% and 64%. Conclusion: SWI combined with IUS in a two-step manner is an accurate way to evaluate patients with chronic diarrhea who have increased SBWT and is not only able to differentiate inflammatory from fibrotic bowel wall thickening but also helps to form an etiological diagnosis.
- 23 November 2023
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 52 (2) , 163-175
Use of shear wave imaging with intestinal ultrasonography in patients with chronic diarrhea
Objective: A retrospective study was designed to determine the role of shear wave elastography (SWE) and intestinal ultrasonography to differentiate between inflammatory and fibrotic bowel strictures by determining Young's modulus (E) and shear wave dispersion (SWD) and to compare its role with contrast-enhanced computed tomography (CECT) in patients with chronic diarrhea and pain abdomen. Methods: Seventy-six patients who had increased small bowel thickness (SBWT) >3 mm, and large bowel wall thickness (LBWT) >4 mm on intestinal ultrasonography (IUS) were evaluated in a two-step manner. The first step involved classifying patients with increased SBWT >3 mm and LBWT >4 mm by use of SWE and dispersion into three groups that is group I (fibrotic), group II (inflammatory) thickening, and group III (mixed-fibrosis and inflammatory) wall thickening. In the second step, etiological classification was done using six gray scale features of IUS that is length and degree of bowel thickening, presence of bowel stratification, Limberg grade of vascularity, status of mesenteric fat, juxta bowel status-nodes, fluid, and fistula formation to reach to a definitive diagnosis. These findings were compared with findings on CECT. Twenty-three patients had diagnosis confirmed by biopsy while 18 underwent surgery with histologic confirmation of operative findings. The sensitivity, specificity and AUROC for both modalities were compared. Results: Group I that is fibrotic group had 33 patients with fibrotic strictures of which fibrotic Crohn's disease (CD)and tuberculosis of the bowel were the dominant types followed by neoplastic and infective causes. In Group II that is inflammatory there were 32 patients with predominantly infective ileo-colitis, and ulcerative colitis patients while 11 patients were present in group III that is (mixed fibrotic and inflammatory) type of bowel wall thickening and were patients of inflammatory CD, infective ileo-colitis. The presence of length of bowel involvement, Limberg grade, mesenteric fat proliferation, and SBWT>9 mm were the statistically significant parameters on IUS which helped to reach to final diagnosis. The sensitivity and specificity of combined SWE with SWD and IUS were 100% and 99% while that of CECT was 78% and 96% respectively with AUROC of 100% and 64%. Conclusion: SWI combined with IUS in a two-step manner is an accurate way to evaluate patients with chronic diarrhea who have increased SBWT and is not only able to differentiate inflammatory from fibrotic bowel wall thickening but also helps to form an etiological diagnosis.
- Open Access
- 28 September 2023
- Published by Medip Academy in International Surgery Journal
- Vol. 10 (10) , 1721-1723
Complex duplication anomalies of the gall bladder
We discuss two patients of complex duplication of gall bladders with variants which have not been described earlier so far. The duplication of gall bladder is an uncommon type of anomaly with incidence of 1 in 4000 patients. Two classification systems by Harlafti and Gross are used to describe the type of anomalies. In this paper we describe two types of duplications of gall bladder one having left double sided gall bladder and the second with asymmetric small size gall bladder with absent cystic duct both of which pose not only diagnostic but surgical implications. The knowledge of both these types is important to both the diagnostician as well as the surgeon in order to prevent complications and obtain accurate results.
- 28 September 2023
- Published by Medip Academy in International Surgery Journal
- Vol. 10 (10) , 1721-1723
Open AccessComplex duplication anomalies of the gall bladder
We discuss two patients of complex duplication of gall bladders with variants which have not been described earlier so far. The duplication of gall bladder is an uncommon type of anomaly with incidence of 1 in 4000 patients. Two classification systems by Harlafti and Gross are used to describe the type of anomalies. In this paper we describe two types of duplications of gall bladder one having left double sided gall bladder and the second with asymmetric small size gall bladder with absent cystic duct both of which pose not only diagnostic but surgical implications. The knowledge of both these types is important to both the diagnostician as well as the surgeon in order to prevent complications and obtain accurate results.
- Open Access
- 23 September 2023
- Published by Medknow in Journal of Medical Ultrasound
- Vol. 32 (4) , 348-351
The Use of Shear Wave Elastography in the Diagnosis of Prestenotic Phase of Takayasu’s Aortoarteritis
We report the use of shear wave elastography with dispersion imaging in diagnosing a case of prestenotic Takayasu’s arteritis which presented with symptoms of fever of unknown origin with persistently raised C-reactive protein levels. Vessel wall inflammation was detected in the carotid arteries on dispersion and shear wave imaging along with increased wall stiffness which was characteristic of vasculitis seen in a prestenotic phase of Takayasu’s disease. These findings preceded the sonographic finding of vessel wall thickening described as the earliest sign of the disease on routine ultrasonography and not only helped to make an early diagnosis in a patient with a fever of unknown origin but also in the posttreatment follow-up.
- 23 September 2023
- Published by Medknow in Journal of Medical Ultrasound
- Vol. 32 (4) , 348-351
Open AccessThe Use of Shear Wave Elastography in the Diagnosis of Prestenotic Phase of Takayasu’s Aortoarteritis
We report the use of shear wave elastography with dispersion imaging in diagnosing a case of prestenotic Takayasu’s arteritis which presented with symptoms of fever of unknown origin with persistently raised C-reactive protein levels. Vessel wall inflammation was detected in the carotid arteries on dispersion and shear wave imaging along with increased wall stiffness which was characteristic of vasculitis seen in a prestenotic phase of Takayasu’s disease. These findings preceded the sonographic finding of vessel wall thickening described as the earliest sign of the disease on routine ultrasonography and not only helped to make an early diagnosis in a patient with a fever of unknown origin but also in the posttreatment follow-up.
- Open Access
- 1 July 2023
- Published by Medknow in Cancer Research, Statistics, and Treatment
- Vol. 6 (3) , 465
Artificial intelligence in oncology clinical practice: Screening post-radiation mucositis
- 1 July 2023
- Published by Medknow in Cancer Research, Statistics, and Treatment
- Vol. 6 (3) , 465
Open AccessArtificial intelligence in oncology clinical practice: Screening post-radiation mucositis
- Open Access
- 30 December 2022
- Published by Medip Academy in International Surgery Journal
- Vol. 10 (1) , 69-75
Comparison of Amritsar scoring system using quantitative contrast enhanced ultrafast magnetic resonance mammography and diffusion technique with conventional Kaiser scoring system
Background: Magnetic resonance imaging (MRI) mammography has been recommended as a problem solving tool in patients with breast lump for which newer imaging protocols like abbreviated, ultrafast MRI and diffusion MRI are now available. For interpretation lexicons like BIRADS and Kaiser score system are available but there is a scope for improvement of results and need for newer lexicons. Methods: Retrospective study of 175 patients of breast lump who had MRI mammography was done. The lesions were labelled as malignant by Kaiser score system (KSS) and a newer scoring system “Amritsar score system” (AMSS). Final diagnoses was confirmed by histological examination with hormone and Her2neu receptor studies. Statistical analysis was done for correlation, sensitivity, specificity and accuracy along with area under curves and the results compared. Results: Study comprised 32/175 patients with malignant nodules. Mean age of 47.2 (range: 44.2-49.6) years with mean nodule size of 2.2 cm (range 1.8-5.5 cm). ADC and Ktrans, Kep, TTE, MS and IAUC60 showed high correlation with size of malignant nodule. Sensitivity of detection was 87.4%, 87.5%, 88.6%, 71.8% and 80% respectively for ADC, Ktrans, Kep, TTE, MS and IAUC60 while specificities were 94, 88.7, 88.7% 90% and 90% respectively. The sensitivity, specificity and accuracy for KSS and AMSS were 62.5%, 88.9%, 72% and 96.5%, 90% and 94% respectively. Conclusions: AMSS is more accurate than KSS and improves the sensitivity and specificity of cancer detection. Ktrans and ADC imaging parameters not only show high sensitivity for cancer detection but also have a good correlation with the size and nuclear grade to be used as imaging biomarkers.
- 30 December 2022
- Published by Medip Academy in International Surgery Journal
- Vol. 10 (1) , 69-75
Open AccessComparison of Amritsar scoring system using quantitative contrast enhanced ultrafast magnetic resonance mammography and diffusion technique with conventional Kaiser scoring system
Background: Magnetic resonance imaging (MRI) mammography has been recommended as a problem solving tool in patients with breast lump for which newer imaging protocols like abbreviated, ultrafast MRI and diffusion MRI are now available. For interpretation lexicons like BIRADS and Kaiser score system are available but there is a scope for improvement of results and need for newer lexicons. Methods: Retrospective study of 175 patients of breast lump who had MRI mammography was done. The lesions were labelled as malignant by Kaiser score system (KSS) and a newer scoring system “Amritsar score system” (AMSS). Final diagnoses was confirmed by histological examination with hormone and Her2neu receptor studies. Statistical analysis was done for correlation, sensitivity, specificity and accuracy along with area under curves and the results compared. Results: Study comprised 32/175 patients with malignant nodules. Mean age of 47.2 (range: 44.2-49.6) years with mean nodule size of 2.2 cm (range 1.8-5.5 cm). ADC and Ktrans, Kep, TTE, MS and IAUC60 showed high correlation with size of malignant nodule. Sensitivity of detection was 87.4%, 87.5%, 88.6%, 71.8% and 80% respectively for ADC, Ktrans, Kep, TTE, MS and IAUC60 while specificities were 94, 88.7, 88.7% 90% and 90% respectively. The sensitivity, specificity and accuracy for KSS and AMSS were 62.5%, 88.9%, 72% and 96.5%, 90% and 94% respectively. Conclusions: AMSS is more accurate than KSS and improves the sensitivity and specificity of cancer detection. Ktrans and ADC imaging parameters not only show high sensitivity for cancer detection but also have a good correlation with the size and nuclear grade to be used as imaging biomarkers.